Show simple item record

Authordc.contributor.authorPizarro Berdichevsky, Javier 
Authordc.contributor.authorJavier Hitschfeld, Mario 
Authordc.contributor.authorPattillo, Alejandro 
Authordc.contributor.authorBlumel, Bernardita 
Authordc.contributor.authorGonzalez, Silvana 
Authordc.contributor.authorArellano, Marco 
Authordc.contributor.authorCuevas, Rodrigo 
Authordc.contributor.authorAlvo, Jacobo 
Authordc.contributor.authorGorodischer, Ariel 
Authordc.contributor.authorFlores Espinoza, Claudia 
Authordc.contributor.authorGoldman, Howard B. 
Admission datedc.date.accessioned2016-12-21T21:19:26Z
Available datedc.date.available2016-12-21T21:19:26Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationAustralian & New Zealand Journal of Obstetrics & Gynaecology. Volumen: 56 Número: 4 Páginas: 391-397 (2016)es_ES
Identifierdc.identifier.other10.1111/ajo.12467
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/142037
Abstractdc.description.abstractBackgroundThere is no consensus on the relationship between depressive symptoms (DS) and pelvic organ prolapse (POP) symptoms and quality of life (QoL). Our hypothesis was that women with DS and POP have worse symptoms and QoL than those without DS and POP. AimOur aim was to compare two groups of POP patients, those with depressive symptoms and those without, and evaluate the association of symptoms and QoL. Materials and methodsThis planned report is part of a prospective study evaluating the impact of pessary use among symptomatic POP patients. Patients were evaluated by POP quantification (POP-Q), pelvic ultrasound (US), voiding diaries, stress test, pad test, Pelvic Floor Distress Inventory (PFDI-20), Prolapse QoL (P-QoL) and the Goldberg Health Questionnaire (GHQ-12) (psychological health screening for DS when score 5). A sample size of 78 patients was required to demonstrate a 50-point difference in the global PFDI-20 score with 80% power and 95% probability. ResultsNinety-one women with POP were included. GHQ-12 was positive in 47 (51.6%) patients. No differences were found in POP-Q, pad and stress test between those with a positive GHQ-12 and those without. However, GHQ-12 was associated with higher PFDI-20 scores and higher scores in seven of nine P-QoL domains. GHQ-12 persisted as an independent risk factor for worse P-QoL scores after multivariable analysis. ConclusionA positive' screening for DS was associated with worse PFDI-20 and P-QoL scores despite no difference in objective measurements. It may be that depressed patients interpret their symptoms differently.es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherWiley-Blackwelles_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceAustralian & New Zealand Journal of Obstetrics & Gynaecologyes_ES
Keywordsdc.subjectsigns and symptomses_ES
Keywordsdc.subjectquality of lifees_ES
Keywordsdc.subjectpelvic organ prolapsees_ES
Keywordsdc.subjectdepressiones_ES
Títulodc.titleAssociation between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patientses_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorC. R. B.es_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile